✦ LIBER ✦

Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Scribed by Mamoru Tsukuda; Junichi Ishitoya; Hideki Matsuda; Choichi Horiuchi; Takahide Taguchi; Masahiro Takahashi; Goshi Nishimura; Mariko Kawakami; Makiko Watanabe; Tatsuo Niho; Toshiro Kawano; Yoichi Ikeda; Yasunori Sakuma; Osamu Shiono; Masanori Komatsu

Publisher: Springer
Year: 2009
Tongue: English
Weight: 249 KB
Volume: 66
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1217-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of combined chemotherapy w

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Yasukazu Mikami; Yuji Tanigaki; Hideaki Katori; Choichi Horiuchi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 234 KB

Comparison of hyperfractionation and con

Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ Hideaki Katori; Mamoru Tsukuda; Kiichi Watai 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 319 KB

Pilot study of intraoperative chemothera

Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck

✍ Ozlem E. Tulunay; Ileana I. Enamorado; Omer Kucuk; Lance K. Heilbrun; Jose E. Ot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Phase II trial of dose-dense paclitaxel,

Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck

✍ Ricardo Hitt; Antonio Jimeno; Jose María Millán; Daniel Castellano; Hernán Corté 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 4 views

## Abstract ## BACKGROUND The current study evaluated the feasibility and clinical activity of a combination of paclitaxel, cisplatin, 5‐fluorouracil (5‐FU), and leucovorin administered on a biweekly schedule to patients with recurrent or unresectable squamous cell carcinoma of the head and neck (

A phase II trial of cisplatin, methotrex

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

✍ Francesco Caponigro; Pasquale Comella; Paolo Marcolin; Francesco Russo Spena; Ma 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Background: Induction chemotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (scchn) might improve survival with respect to radiation therapy alone. furthermore, chemotherapy represents the only therapeutic option in metastatic head and neck carcinoma. ## Methods: